IE
PLSE icon

Israel Englander’s Pulse Biosciences PLSE Stock Holding History

Israel Englander’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$651K Sell
23,488
-32,329
-58% -$763K ﹤0.01% 4600
2026
Q1 		$1.21M Buy
+55,817
New +$1.03M ﹤0.01% 4260
2025
Q2 		– Sell
-86,574
Closed -$1.39M – 6226
2025
Q1 		$1.39M Buy
+86,574
New +$1.61M ﹤0.01% 4105
2024
Q4 		– Sell
-62,353
Closed -$1.09M – 6346
2024
Q3 		$1.09M Buy
62,353
+23,817
+62% +$406K ﹤0.01% 4198
2024
Q2 		$431K Sell
38,536
-2,791
-7% -$26.3K ﹤0.01% 4677
2024
Q1 		$360K Buy
+41,327
New +$380K ﹤0.01% 5024
2023
Q4 		– Sell
-47,754
Closed -$192K – 6434
2023
Q3 		$192K Buy
47,754
+11,873
+33% +$73.8K ﹤0.01% 5138
2023
Q2 		$258K Buy
35,881
+1,555
+5% +$9.93K ﹤0.01% 4988
2023
Q1 		$115K Sell
34,326
-10,719
-24% -$32.3K ﹤0.01% 5375
2022
Q4 		$125K Sell
45,045
-13,606
-23% -$30.6K ﹤0.01% 5504
2022
Q3 		$135K Sell
58,651
-61,685
-51% -$100K ﹤0.01% 5850
2022
Q2 		$184K Buy
+120,336
New +$303K ﹤0.01% 5678
2021
Q3 		– Sell
-17,535
Closed -$288K – 7137
2021
Q2 		$288K Buy
+17,535
New +$334K ﹤0.01% 5761
2020
Q4 		– Sell
-18,780
Closed -$221 – 5500
2020
Q3 		$221 Buy
18,780
+17
+0.1% +$183 ﹤0.01% 4022
2020
Q2 		$196K Buy
+18,763
New +$169K ﹤0.01% 3851
2018
Q1 		– Sell
-12,272
Closed -$290K – 3986
2017
Q4 		$290K Buy
+12,272
New +$290K ﹤0.01% 3371
2017
Q2 		– Sell
-11,975
Closed -$244K – 3766
2017
Q1 		$244K Buy
+11,975
New +$163K ﹤0.01% 3131
2016
Q4 		– Sell
-30,674
Closed -$193K – 3637
2016
Q3 		$193K Buy
+30,674
New +$156K ﹤0.01% 2994

Other funds holding PLSE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Israel Englander's PLSE Position: Q2 2026 in Review

Israel Englander reduced its Pulse Biosciences (PLSE) stake by 58% in Q2 2026, selling an estimated $763K and leaving 23,488 shares worth $651K. The position accounts for ﹤0.01% of the portfolio, ranked #4600.

Israel Englander first reported a position in PLSE in Q3 2016 and has held it in 18 quarters since. The position peaked at $1.39M in Q1 2025. 105 funds tracked by Wall St. Rank hold PLSE as of Q2 2026.

  • Israel Englander held 23,488 shares of Pulse Biosciences worth $651K as of Q2 2026.
  • Israel Englander sold 32,329 Pulse Biosciences shares in Q2 2026, an estimated $763K.
  • Pulse Biosciences made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4600 holding.
  • Israel Englander first reported a position in Pulse Biosciences in Q3 2016 and has held it in 18 quarters since.
  • Israel Englander's Pulse Biosciences position peaked at $1.39M in Q1 2025.
  • 105 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.